These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2768794)

  • 21. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.
    Berzigotti A; Reverter E; García-Criado A; Abraldes JG; Cerini F; García-Pagán JC; Bosch J
    J Hepatol; 2013 Oct; 59(4):717-22. PubMed ID: 23669282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis.
    Finucci G; Bellon S; Merkel C; Mormino P; Tirelli M; Gatta A; Zuin R
    Scand J Gastroenterol; 1991 Sep; 26(9):951-60. PubMed ID: 1947788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices.
    Merkel C; Bolognesi M; Bellon S; Zuin R; Noventa F; Finucci G; Sacerdoti D; Angeli P; Gatta A
    Gastroenterology; 1992 Mar; 102(3):973-9. PubMed ID: 1537533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
    Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.
    Merkel C; Bolognesi M; Angeli P; Noventa F; Caregaro L; Sacerdoti D; Gatta A
    Am J Gastroenterol; 1989 Jul; 84(7):717-22. PubMed ID: 2787099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M; Watanabe G
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrinsic hepatic clearance of indocyanine green in the pig: dependence on plasma protein concentration.
    Ott P; Keiding S; Bass L
    Eur J Clin Invest; 1992 May; 22(5):347-57. PubMed ID: 1592087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.
    Merkel C; Bolognesi M; Bellon S; Bianco S; Honisch B; Lampe H; Angeli P; Gatta A
    Gut; 1992 Jun; 33(6):836-42. PubMed ID: 1624169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis.
    Albers I; Hartmann H; Bircher J; Creutzfeldt W
    Scand J Gastroenterol; 1989 Apr; 24(3):269-76. PubMed ID: 2734585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.
    Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
    Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.
    Chen CY; Tsai WL; Lin PJ; Shiesh SC
    Clin Chem Lab Med; 2011 Nov; 49(11):1817-21. PubMed ID: 21851314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.
    Kaplan DE; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Knott A; Pedrosa M; Pocha C; Mehta R; Duggal M; Skanderson M; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2333-41.e1-6. PubMed ID: 26188137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis.
    Vinel JP; Caucanas JP; Combis JM; Cales P; Voigt JJ; Pascal JP
    J Hepatol; 1989 May; 8(3):302-7. PubMed ID: 2732444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis.
    Stauber RE; Wagner D; Stadlbauer V; Palma S; Gurakuqi G; Kniepeiss D; Iberer F; Smolle KH; Haas J; Trauner M
    Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of portacaval shunt on drug disposition in patients with cirrhosis.
    Pomier-Layrargues G; Huet PM; Villeneuve JP; Marleau D
    Gastroenterology; 1986 Jul; 91(1):163-7. PubMed ID: 3710065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment by pulse dye-densitometry indocyanine green (ICG) clearance test of hepatic function of patients before cardiac surgery: its value as a predictor of serious postoperative liver dysfunction.
    Watanabe Y; Kumon K
    J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):299-303. PubMed ID: 10392681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pre-and postoperative indocyanine green retention rate as a marker of liver functional reserve in cirrhotic patients].
    Song Y
    Zhonghua Wai Ke Za Zhi; 1993 Feb; 31(2):102-5. PubMed ID: 8222999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.